Shares of Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) traded down 3.8% during trading on Wednesday. The stock traded as low as C$0.25 and last traded at C$0.26. 384,329 shares were traded during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Down 3.8%
The stock has a market capitalization of C$52.28 million and a price-to-earnings ratio of -0.37. The business has a fifty day moving average of C$0.26 and a 200 day moving average of C$0.26. The company has a debt-to-equity ratio of 35.45, a current ratio of 2.97 and a quick ratio of 2.61.
Emerald Health Therapeutics Company Profile
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.
See Also
- Five stocks we like better than Emerald Health Therapeutics
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
